<DOC>
	<DOCNO>NCT02551549</DOCNO>
	<brief_summary>A multiple ascending dose study evaluate safety , tolerability , pharmacokinetics CD101 Injection Healthy Subjects .</brief_summary>
	<brief_title>An Ascending Multiple Dose Study CD101 IV Healthy Subjects</brief_title>
	<detailed_description>This Phase 1 , single-center , prospective , randomize , double-blind study multiple ascending dos ( MAD ) CD101 Injection administer IV healthy adult subject . In study , subject 3 cohort 8 subject randomize receive multiple IV dose CD101 Injection placebo infusion . Dose level CD101 Injection assess follow ascend multiple-dose regimen .</detailed_description>
	<criteria>Men must surgically sterilize use contraception , No significant finding physical exam , ECG , clinical laboratory test , Body mass index ( BMI ) 18.5 32.0 kg/m2 , inclusive Must provide write informed consent Females child bear potential Signs symptom acute illness chronic disease Use prescription medication within 28 day Use OTC , supplement , herbal within 14 day Current smoker Previous participation clinical study within 28 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Subjects</keyword>
</DOC>